Literature DB >> 3907890

Increased plasma glycosidase and protease activity in uraemia: possible role in the aetiology of the anaemia of chronic renal failure.

J S Shannon, T R Lappin, G E Elder, G M Roberts, M G McGeown, J M Bridges.   

Abstract

We have measured plasma N-acetyl-beta-D-glucosaminidase (EC 3.2.1.30) and neuraminidase (EC 3.2.1.18) activities as markers of glycosidase activity and immunoreactive trypsin (EC 3.4.21.4) levels as a marker of proteolytic potential in the plasma of normal and uraemic subjects. The levels of all of these enzymes are significantly elevated in the plasma of uraemic subjects when compared to normal. We have postulated that the combined attack of glycosidases and proteases on erythropoietin will lead to fragmentation of this glycoprotein hormone with loss of activity. This may be a major contributory cause to the anaemia of chronic renal failure.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3907890     DOI: 10.1016/0009-8981(85)90353-5

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


  2 in total

1.  Epoetin beta pegol, but not recombinant erythropoietin, retains its hematopoietic effect in vivo in the presence of the sialic acid-metabolizing enzyme sialidase.

Authors:  Ken Aizawa; Ryohei Kawasaki; Yoshihito Tashiro; Michinori Hirata; Koichi Endo; Yasushi Shimonaka
Journal:  Int J Hematol       Date:  2016-04-15       Impact factor: 2.490

2.  A Comparative Study of the Hemoglobin-Maintaining Effects Between Epoetin-β Pegol and Darbepoetin-α in Patients with Chronic Kidney Disease During 3 Months Before Dialysis Initiation.

Authors:  Satoru Oka; Yoko Obata; Kenta Torigoe; Miki Torigoe; Shinichi Abe; Kumiko Muta; Yuki Ota; Mineaki Kitamura; Satoko Kawasaki; Misaki Hirose; Tadashi Uramatsu; Hiroshi Yamashita; Hideyuki Arai; Hiroshi Mukae; Tomoya Nishino
Journal:  Drugs R D       Date:  2017-09
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.